- Home
- AXR vs COYA Comparison
AXR vs COYA Comparison
Compare AXR & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXR
- COYA
- Stock Information
- Founded
- AXR 1961
- COYA 2020
- Country
- AXR United States
- COYA United States
- Employees
- AXR N/A
- COYA N/A
- Industry
- AXR Homebuilding
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- AXR Real Estate
- COYA Health Care
- Exchange
- AXR Nasdaq
- COYA Nasdaq
- Market Cap
- AXR 114.8M
- COYA 99.8M
- IPO Year
- AXR N/A
- COYA 2022
- Fundamental
- Price
- AXR $23.85
- COYA $6.11
- Analyst Decision
- AXR
- COYA Strong Buy
- Analyst Count
- AXR 0
- COYA 4
- Target Price
- AXR N/A
- COYA $16.50
- AVG Volume (30 Days)
- AXR 14.7K
- COYA 65.9K
- Earning Date
- AXR 09-12-2025
- COYA 08-11-2025
- Dividend Yield
- AXR N/A
- COYA N/A
- EPS Growth
- AXR 472.07
- COYA N/A
- EPS
- AXR 2.41
- COYA N/A
- Revenue
- AXR $58,052,000.00
- COYA $3,685,107.00
- Revenue This Year
- AXR $120,108.69
- COYA $106.97
- Revenue Next Year
- AXR $8.16
- COYA N/A
- P/E Ratio
- AXR $9.82
- COYA N/A
- Revenue Growth
- AXR 30.35
- COYA N/A
- 52 Week Low
- AXR $17.60
- COYA $4.65
- 52 Week High
- AXR $39.68
- COYA $10.24
- Technical
- Relative Strength Index (RSI)
- AXR 68.04
- COYA 58.05
- Support Level
- AXR $22.71
- COYA $5.97
- Resistance Level
- AXR $25.01
- COYA $6.45
- Average True Range (ATR)
- AXR 1.06
- COYA 0.34
- MACD
- AXR 0.26
- COYA 0.05
- Stochastic Oscillator
- AXR 74.18
- COYA 64.89
About AXR AMREP Corporation
Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve obtaining approvals and selling both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. The Company accounts for land sales, home sales, and other revenues. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.